A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with aids

Stephen L. Hutcherson; René Lanz

doi:10.1016/S0002-9394(02)01327-2

A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with aids

Stephen L. Hutcherson
, René Lanz

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	467-474
Number of pages	8
Journal	American Journal of Ophthalmology
Volume	133
Issue number	4
DOIs	https://doi.org/10.1016/S0002-9394(02)01327-2
State	Published - 2002
Externally published	Yes

ASJC Scopus Subject Areas

Ophthalmology

Access to Document

10.1016/S0002-9394(02)01327-2

OpenUrl availability

Full text

Cite this

@article{ccc967c7a162408e95b018c8fd369208,

title = "A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with aids",

author = "Hutcherson, \{Stephen L.\} and Ren{\'e} Lanz",

note = "PURPOSE: To assess the efficacy of intravitreous fomivirsen sodium, an antisense oligonucleotide, for newly diagnosed peripheral cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). DESIGN: Randomized treatment intervention clinical trial. METHODS: A multicenter, prospective, and randomized clinical trial compared immediate treatment of CMV retinitis with fomivirsen (165 μg administered intravitreously) to deferral of treatment until CMV retinitis lesions progressed by standard definitions.",

year = "2002",

doi = "10.1016/S0002-9394(02)01327-2",

language = "English",

volume = "133",

pages = "467--474",

journal = "American Journal of Ophthalmology",

issn = "0002-9394",

number = "4",

}

TY - JOUR

T1 - A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with aids

AU - Hutcherson, Stephen L.

AU - Lanz, René

N1 - PURPOSE: To assess the efficacy of intravitreous fomivirsen sodium, an antisense oligonucleotide, for newly diagnosed peripheral cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). DESIGN: Randomized treatment intervention clinical trial. METHODS: A multicenter, prospective, and randomized clinical trial compared immediate treatment of CMV retinitis with fomivirsen (165 μg administered intravitreously) to deferral of treatment until CMV retinitis lesions progressed by standard definitions.

PY - 2002

Y1 - 2002

UR - https://www.scopus.com/pages/publications/0036202668

UR - https://www.scopus.com/pages/publications/0036202668#tab=citedBy

U2 - 10.1016/S0002-9394(02)01327-2

DO - 10.1016/S0002-9394(02)01327-2

M3 - Article

SN - 0002-9394

VL - 133

SP - 467

EP - 474

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

IS - 4

ER -

A randomized controlled clinical trial of intravitreous fomivirsen for treatment of newly diagnosed peripheral cytomegalovirus retinitis in patients with aids

ASJC Scopus Subject Areas

Access to Document

OpenUrl availability

Other files and links

Cite this